Publications and communications of Christophe BOVY

Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751
* These authors have contributed equally to this work.

ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344.

GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337.

Erpicum, P., Grosch, S., Bonvoisin, C., Bouquegneau, A., Weekers, L., Radermacher, L., Jouret, F., LEJEUNE, M., Hougrand, O., & Bovy, C. (2022). The Case | An unusual cause of renal vascular thrombi after kidney transplantation. Kidney International, 101 (2), 427-428. doi:10.1016/j.kint.2021.08.008

Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386

BOUQUEGNEAU, A., ERPICUM, P., GROSCH, S., HABRAN, L., HOUGRAND, O., HUART, J., KRZESINSKI, J.-M., Misset, B., Hayette, M.-P., DELVENNE, P., BOVY, C., Kylies, D., huber, T. B., Puelles, V. G., DELANAYE, P., & Jouret, F. (2021). COVID-19-associated nephropathy includes tubular necrosis and capillarycongestion, with evidence of SARS-CoV-2 in the nephron. Kidney International. doi:10.34067/KID.0006992020

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0

BOVY, C., DELANAYE, P., JOURET, F., & KRZESINSKI, J.-M. (2020). Nouveautés thérapeutiques en Néphrologie : 10 ans d'avancées. Revue Médicale de Liège, 75 (5-6), 336-343.

ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114.

Résimont, G., DUBOIS, B., BOVY, C., Collart, F., & Krzesinski, J.-M. (2020). La dialyse chronique face à la COVID-19. Revue Médicale de Liège. Supplément, 75 (S1), 41-s47.

HUART, J., GROSCH, S., BOVY, C., Moutschen, M., & Krzesinski, J.-M. (April 2017). IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrology, 18, 139. doi:10.1186/s12882-017-0561-2

JADOT, V., Krzesinski, J.-M., VON FRENCKELL, C., BOVY, C., & BOUQUEGNEAU, A. (2017). La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie et Thérapeutique, 14, 1-12. doi:10.1016/j.nephro.2017.05.002

LOVINFOSSE, P.* , Weekers, L.* , BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & JOURET, F. (2016). Fluorodeoxyglucose F Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. American Journal of Transplantation. doi:10.1111/ajt.13429
* These authors have contributed equally to this work.

LOVINFOSSE, P., WEEKERS, L., BOVY, C., BONVOISIN, C., GROSCH, S., KRZESINSKI, J.-M., Hustinx, R., & Jouret, F. (13 September 2015). 18FDG-PET/CT IMAGING IN SUSPECTED ACUTE RENAL ALLOGRAFT REJECTION [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

WEEKERS, L., LOVINFOSSE, P., BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (September 2015). Place de la tomographie à émission de positons au 18FDG couplée à la tomodensitométrie en cas de suspicion de rejet aigu du greffon rénal. Néphrologie et Thérapeutique, 11 (5), 280.

WEEKERS, L., De Tullio, P., BOVY, C., Poma, L., Marée, R., BONVOISIN, C., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (30 January 2015). Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury. American Journal of Translational Research, 7 (1), 128-138.

Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7

Warling, O., BOVY, C., COIMBRA MARQUES, C., Noterdaeme, T., DELWAIDE, J., & LOUIS, E. (28 April 2014). Overlap syndrome consisting of PSC-AIH with concomitant presence of a membranous glomerulonephritis and ulcerative colitis. World Journal of Gastroenterology, 20 (16), 4811-4816. doi:10.3748/wjg.v20.i16.4811

MILICEVIC, M., GROSCH, S., Krzesinski, J.-M., Moutschen, M., & BOVY, C. (22 January 2014). Un cas particulier d'amyloïdose AA [Paper presentation]. Confrontations anatomocliniques en pathologie rénale et vasculaire, Paris, France.

Hanssen, O., CASTERMANS, E., BOVY, C., WEEKERS, L., ERPICUM, P., DUBOIS, B., Bours, V., Krzesinski, J.-M., & Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. NDT Plus, 7, 282-285. doi:10.1093/ckj/sfu019

Jouret, F., De Tullio, P., Poma, L., Marée, R., BOVY, C., & DEFRAIGNE, J. (2014). ACTIVATION OF THE CALCIUM-SENSING RECEPTOR BEFORE RENAL ISCHEMIA/REPERFUSION EXACERBATES KIDNEY INJURY IN MOUSE. Transplant International, 27 suppl 1, 15-20.

BOVY, C., Crismer, A., & KRZESINSKI, J.-M. (04 May 2013). Traitement de suppléance de l'insuffisance rénale terminale : aspects éthiques et économiques, rôles du médecin généraliste [Paper presentation]. Mini symposium Enseignement Post-Universitaire, Liège, Belgium.

VAN OVERMEIRE, L., Goffin, E., Krzesinski, J.-M., Saint-Remy, A., Bovy, P., Cornet, G., & BOVY, C. (2013). Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product’ or with biocompatible ‘normal pH/low glucose degradation product’ dialysates: does it matter? Nephrology Dialysis Transplantation, 1946-51. doi:10.1093/ndt/gfs433

GROSCH, S., VAN OVERMEIRE, L., Krzesinski, J.-M., & BOVY, C. (2011). La glomérulonéphrite fibrillaire non amyloïde : une cause rare de syndrome néphrotique. Néphrologie et Thérapeutique, 7, 494-498. doi:10.1016/j.nephro.2011.03.001

Bovy, C., & Krzesinski, J.-M. (27 April 2010). Le syndrome néphrotique [Paper presentation]. Réunion scientifique, Liège, Belgium.

Le Goff, C., Kaux, J.-F., Bovy, C., Da Silva, A., & Chapelle, J.-P. (March 2010). Comparaison des taux de BNP et de NT-proBNP chez des patients insuffisants rénaux pour prévenir l'insuffisance cardiaque. Biotribune Magazine, 34, 6-9. doi:10.1007/s11834-010-0004-x

BOUQUEGNEAU, A., Longton, J., Bovy, C., & Krzesinski, J.-M. (2010). La néphropathie tubulo-interstitielle aiguë: une cause rare d’insuffisance rénale aiguë. Revue Médicale de Liège, 65 (7-8), 459-463.

Teixeira, J., Le Goff, C., Aldenhoff, M.-C., Bovy, C., Dubois, B., Krzesinski, J.-M., & Chapelle, J.-P. (October 2009). Comparison of myocardial makers for assessing cardiovascular and all cause 3-year mortality in dialysis patients [Poster presentation]. 20th international Congress of Clinical Chemistry and Laboratory Medicine, 35th Brazilian Congress of Clinical Analysis and 8th Brazilian Congress of Clinical Cytology, Fortaleza, Brazil.

Le Goff, C., Bovy, C., Da Silva, A., Krzesinski, J.-M., & Chapelle, J.-P. (2009). Comparison of BNP and NT-proBNP performances for assessing heart failure in a population of patients with high incidence of with renal insufficiency. Annales de Biologie Clinique, 67 (1).

Couvreur, T., Szepetiuk, G., Meunier, P., Delbecque, K., Detry, O., Bovy, C., & de Leval, L. (November 2008). L'image du mois. La polykystose rénale autosomique dominante. Revue Médicale de Liège, 63 (11), 637-639.

Teixeira, J., Aldenhoff, M.-C., Bovy, C., Dubois, B., Krzesinski, J.-M., & Chapelle, J.-P. (May 2008). Low creatine kinase MM (CK-MM) levels are strongly associated with adverse outcome in haemodialysis patients [Poster presentation]. International Symposium of Laboratory Medicine - Brussels 2008, Bruxelles, Belgium.

Le Goff, C., Bovy, C., Aldenhoff, M.-C., Krzesinski, J.-M., & Chapelle, J.-P. (December 2007). Intérêt pronostique à trois ans de la troponine T cardiaque (cTnT) et du fragment N-terminal du propeptide du peptide natriurétique de type B (NT-proBNP) chez les patients hémodialysés. Immuno-Analyse and Biologie Spécialisée, 22 (6), 377-383. doi:10.1016/j.immbio.2007.09.002

Bovy, C., Parotte, M.-C., & Krzesinski, J.-M. (October 2007). Clinico-pathological prognostic factors of IgA vasculitis. Acta Clinica Belgica, 62 (5), 369.

Parotte, M.-C., Bovy, C., & Krzesinski, J.-M. (29 August 2007). Utilité du mycophénolate mofétil en pathologie rénale en dehors de la transplantation. Revue Médicale Suisse, 3, 1899-1905.

Bovy, C., Gothot, A., Krzesinski, J.-M., Warling, X., & Beguin, Y. (20 January 2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation, 11, 1156-1162. doi:10.1093/ndt/gfl765

Le Goff, C., Aldenhoff, M.-C., Bovy, C., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Interest of plasma NT-proBNP determinations for 3-year prognosis in hemodialyzed patients [Poster presentation]. 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Parotte, M.-C., Bovy, C., & Krzesinski, J.-M. (2007). La dapsone: une économie de corticoïdes dans le traitement du purpura rhumatoïde? A propos d'un cas observé. Revue Médicale de Liège, 62, 710-712.

Le Goff, C., Aldenhoff, M.-C., Bovy, C., Krzesinski, J.-M., & Chapelle, J.-P. (26 October 2006). Interest of cTnT and NT-proBNP for 3-year prognosis in hemodialyzed patients [Paper presentation]. CORATA, Brugges, Belgium.

Bovy, C. (2006). Influence de l'activité érythropoïétique sur le métabolisme et le monitoring martial: Un rôle pour les indices des érythrocytes matures [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315255

Krzesinski, J.-M., Delanaye, P., Bovy, C., & Cavalier, E. (2006). Place de la Biologie Clinique dans l'évolution de l'insuffisance rénale et de ses complications [Paper presentation]. Formation continue en Biologie Clinique, Liège, Belgium.

Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x

Bovy, C., Delanaye, P., Radermecker, R., Hamoir, E., Maweja, S., & Krzesinski, J.-M. (April 2005). Comment j'explore ... l'hypertension artérielle par excès de minéralocorticoides. Revue Médicale de Liège, 60 (4), 255-63.

Bataille, Y., Bovy, C., Lancellotti, P., Melchior, V., Delbecque, K., Beguin, Y., & Krzesinski, J.-M. (2005). Primary amyloidosis (AL) as a cause of nephrotic syndrome. Acta Clinica Belgica, 60 (2), 94-7. doi:10.1179/acb.2005.017

Bovy, C., Gothot, A., Krzesinski, J.-M., & Beguin, Y. (2005). Mature erythrocyte indices: new markers of iron availability. Haematologica, 90 (4), 549-51.

Bataille, Y., Bovy, C., Pierard, L., & LANCELLOTTI, P. (October 2004). L'image du mois. Amylose cardiaque. Revue Médicale de Liège, 59 (10), 549.

Bovy, C., Krzesinski, J.-M., Gothot, A., & Beguin, Y. (2004). Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica, 89 (6), 748-9.

Delanaye, P., Bovy, C., de Leval, L., Fassotte, M.-F., Witvrouw, N., Dechenne, C., Tassin, F., & Krzesinski, J.-M. (2004). Back pain and renal failure. The Lancet, 364 (9449), 1992. doi:10.1016/S0140-6736(04)17484-9

Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Hypochromic mature erythrocytes: a specific marker of iron deficiency. Acta Clinica Belgica, 58-3 (4), 325.

Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey. Acta Clinica Belgica, 58-3 (4), 328.

Chapelle, J.-P., Dubois, B., Bovy, C., Aldenhoff, M.-C., Gielen, J., & Rorive, G. (2002). Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clinical Chemistry and Laboratory Medicine, 40 (3), 240-245. doi:10.1515/CCLM.2002.039

Pincemail, J., Bovy, C., Chapelle, J.-P., Gielen, J., Defraigne, J., & Rorive, G. (2001). Markers of oxidative stress limited to increased risk of cardiovascular disease in chronic hemodialysis patients. Free Radical Biology and Medicine, 31 (suppl), 345.

Bovy, C., Dubois, B., Weekers, L., Krzesinski, J.-M., & Rorive, G. (2000). Iron monitoring under vitamin C therapy in hemodialysed patients treated with erythropoietin. Nephrology Dialysis Transplantation, 15 (9), 156.

Bovy, C., Tsobo, C., Crapanzano, L., Rorive, G., Beguin, Y., Albert, A., & Paulus, J.-M. (1999). Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney International, 56 (3), 1113-9. doi:10.1046/j.1523-1755.1999.00627.x

BOVY, C., Saint-Remy, A., Juchmes, A., & Rorive, G. (1998). Lipids, risk factor in hemodialysed patients? Nephrology Dialysis Transplantation, 13, 828.

BOVY, C., Saint-Remy, A., & Rorive, G. (1997). Intravenous or subcutaneous administration of erythropoietin (rHu-EPO)- what to choose? Nephrology Dialysis Transplantation, 189.

BOVY, C., DUBOIS, B., popovic, A., Saint-Remy, A., & Rorive, G. (1995). Mode of administration of Erythropoetin (rHu-Epo)- Does it matter? Nephrology Dialysis Transplantation, 10, 1951-1952.